Institutional investors purchased a net $2.3 million shares of DXCM during the quarter ended September 2017 and now own 129.67% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Medical Specialties industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 5.5 Million shares of DexCom Inc